









Mercados
/
Ações
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

57.500USD

+1.440+2.57%

Horário de mercado （ET）Cotações atrasadas em 15 min

3.91BValor de mercado

14.43P/L TTM



Lantheus Holdings Inc

57.500

+1.440+2.57%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Lantheus Holdings Inc Empresa

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol. It has pre-clinical assets, specifically the TROP2 and DUNP19.

Informações de Lantheus Holdings Inc



Código da empresaLNTH

Nome da EmpresaLantheus Holdings Inc

Data de listagemJun 25, 2015

CEOMr. Brian A. Markison

Número de funcionários808

Tipo de títulosOrdinary Share

Fim do ano fiscalJun 25

Endereço331 Treble Cove Road

CidadeNORTH BILLERICA

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal01862

Telefone19786718001

Sitehttps://www.lantheus.com/

Código da empresaLNTH

Data de listagemJun 25, 2015

CEOMr. Brian A. Markison

Executivos da empresa Lantheus Holdings Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+34.47%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+450.62%

Mr. Samuel R. (Sam) Leno

Independent Director

Ms. Jamie Spaeth

Chief People Officer

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

Detalhamento da receita

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

PYLARIFY

250.64M

0.00%

DEFINITY

83.94M

0.00%

TechneLite

24.98M

0.00%

Strategic partnerships and other

11.59M

0.00%

Other precision diagnostics

6.89M

0.00%

Sem dados

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

PYLARIFY

250.64M

0.00%

DEFINITY

83.94M

0.00%

TechneLite

24.98M

0.00%

Strategic partnerships and other

11.59M

0.00%

Other precision diagnostics

6.89M

0.00%

Distribuição de ações

Atualizado em: qua, 8 de out

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

11.03%

Janus Henderson Investors

10.21%

The Vanguard Group, Inc.

10.03%

Fidelity Management & Research Company LLC

6.08%

Farallon Capital Management, L.L.C.

4.88%

Outro

57.78%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

11.03%

Janus Henderson Investors

10.21%

The Vanguard Group, Inc.

10.03%

Fidelity Management & Research Company LLC

6.08%

Farallon Capital Management, L.L.C.

4.88%

Outro

57.78%

Tipos de investidores

Investidores

Proporção

Investment Advisor

58.42%

Investment Advisor/Hedge Fund

44.78%

Hedge Fund

6.94%

Research Firm

3.61%

Individual Investor

2.32%

Pension Fund

1.92%

Bank and Trust

1.50%

Sovereign Wealth Fund

0.75%

Venture Capital

0.11%

Participação acionária institucional



Atualizado em: dom, 5 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

1003

80.77M

118.79%

-6.50M

2025Q2

1039

82.20M

120.88%

-4.84M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

2023Q2

790

72.85M

106.61%

-3.94M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

7.50M

11.03%

-294.68K

-3.78%

Jun 30, 2025

Janus Henderson Investors

6.94M

10.21%

+677.11K

+10.81%

Jun 30, 2025

The Vanguard Group, Inc.

6.82M

10.03%

-163.58K

-2.34%

Jun 30, 2025

Fidelity Management & Research Company LLC

4.13M

6.08%

+1.96M

+90.51%

Jun 30, 2025

Farallon Capital Management, L.L.C.

3.32M

4.88%

-3.41M

-50.67%

Aug 20, 2025

State Street Investment Management (US)

2.56M

3.76%

-76.88K

-2.92%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.78M

2.61%

-532.00

-0.03%

Jun 30, 2025

Wellington Management Company, LLP

1.72M

2.53%

+810.23K

+89.12%

Jun 30, 2025

Westfield Capital Management Company, L.P.

1.50M

2.2%

-94.07K

-5.92%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

1.43M

2.1%

+13.93K

+0.99%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: seg, 6 de out

Nome

Proporção

Invesco S&P MidCap 400 GARP ETF

1.59%

SPDR S&P Health Care Equipment ETF

1.23%

Janus Henderson US Sustainable Equity ETF

0.81%

Invesco S&P MidCap 400 Pure Growth ETF

0.73%

First Trust Small Cap US Equity Select ETF

0.73%

Distillate Small/Mid Cash Flow ETF

0.68%

Federated Hermes MDT Small Cap Core ETF

0.54%

Gotham 1000 Value ETF

0.48%

Pacer US Cash Cows Growth ETF

0.47%

Invesco S&P MidCap Quality ETF

0.42%

Ver Mais

Invesco S&P MidCap 400 GARP ETF

Proporção1.59%

SPDR S&P Health Care Equipment ETF

Proporção1.23%

Janus Henderson US Sustainable Equity ETF

Proporção0.81%

Invesco S&P MidCap 400 Pure Growth ETF

Proporção0.73%

First Trust Small Cap US Equity Select ETF

Proporção0.73%

Distillate Small/Mid Cash Flow ETF

Proporção0.68%

Federated Hermes MDT Small Cap Core ETF

Proporção0.54%

Gotham 1000 Value ETF

Proporção0.48%

Pacer US Cash Cows Growth ETF

Proporção0.47%

Invesco S&P MidCap Quality ETF

Proporção0.42%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

